RESUMO
BACKGROUND: Chikungunya virus (CHIKV) is a globally prevalent pathogen, with outbreaks occurring in tropical regions. Chronic pain is the main symptom reported and is associated with decreased mobility and disability. Transcranial direct current stimulation (tDCS) is emerging as a new therapeutic tool for chronic arthralgia. OBJECTIVE: To evaluate the effectiveness of 10 consecutive sessions of anodal tDCS on pain (primary outcome) in participants with chronic CHIKV arthralgia. Secondary outcomes included functional status, quality of life, and mood. METHODS: In this randomized, double-blind, placebo-controlled trial, 30 participants with chronic CHIKV arthralgia were randomly assigned to receive either active (n = 15) or sham (n = 15) tDCS. The active group received 10 consecutive sessions of tDCS over M1 using the C3/Fp2 montage (2 mA for 20 min). Visual analog scale of pain (VAS), health assessment questionnaire (HAQ), short-form 36 health survey (SF-36), pain catastrophizing scale, Hamilton anxiety scale (HAS), timed up and go (TUG) test, lumbar dynamometry, 30-s arm curl and 2-min step test were assessed at baseline, day 10 and at 2 follow-up visits. RESULTS: There was a significant interaction between group and time on pain (p = 0.03; effect size 95 % CI 0.9 (-1.67 to -0.16), with a significant time interaction (p = 0.0001). There was no interaction between time and group for the 2-minute step test (p = 0.18), but the groups differed significantly at day 10 (p = 0.01), first follow-up (p = 0.01) and second follow-up (p = 0.03). HAQ and SF-36 improved but not significantly. There was no significant improvement in mental health, and physical tests. CONCLUSION: tDCS appears to be a promising intervention for reducing pain in participants with chronic CHIKV arthralgia, although further research is needed to confirm these findings and explore potential long-term benefits. TRIAL REGISTRATION: Brazilian Registry of Clinical Trials (ReBEC): RBR-245rh7.
RESUMO
ABSTRACT BACKGROUND AND OBJECTIVES: Chikungunya virus (CHIKV) chronic polyarthralgia deteriorates general functionality and work productivity. The objective of this study was to evaluate functionality, pain, quality of life, and sleep quality of individuals with chronic CHIKV arthralgia and correlate them with clinical symptoms, work productivity, and activity impairment. METHODS: This is a descriptive cross-sectional study with 61 chronic CHIKV arthralgia patients. Functionality was assessed using the Health Assessment Questionnaire (HAQ). Pain intensity and interference were measured by using the Visual Analog Scale (VAS) and the Brief Pain Inventory Short Form (BPI), respectively. Quality of life and sleep were evaluated using the Short Form 36 Health Survey (SF-36) and the Pittsburgh Sleep Quality Index (PSQI), respectively. Work Productivity and Activity Impairment (WPAI) questionnaire was used to assess the effects of health in general symptoms on work. RESULTS: Low and moderate level of function was present in 39.4% and 55.7% of the sample, respectively. Moderate pain (5.57 ± 2.25), poor sleep quality (47.54%), and sleep disturbances (42.63%) were also observed. Pearson correlations showed significant correlation between absenteeism and presenteeism with HAQ scores (p = 0.03; r = 0.39 and p = 0.01; r = 0.43, respectively), BPI interference (p = 0.02; r = 0.41 and p = 0.001; r = 0.58, respectively) and SF-36 physical score (p = 0.007; r = -0.49 and p = 0.01; r = 0.58, respectively). Activity impairment showed a significant correlation with HAQ (p = 0.01; r = 0.44), BPI interference (p = 0.006; r = 0.5), SF-36 physical score (p = 0.01; r = -0.6) and SF-36 total score (p = 0.01; r = -0.44). Overall work productivity loss only correlated with BPI interference (p = 0.04; r = 0.37). CONCLUSION: These results suggest that CHIKV chronic arthralgia showed bilateral moderate pain in large joints that impacts activities of daily life, work productivity, and functional activity. HIGHLIGHTS Chronic chikungunya reduces functionality and causes moderate pain and poor sleep quality Clinical symptoms impact daily living activity, work productivity, and activity impairment. Functionality, pain, and sleep correlate with occupational performance.
RESUMO JUSTIFICATIVA E OBJETIVOS: A poliartralgia crônica do vírus Chikungunya (CHIKV) deteriora a funcionalidade e a produtividade do trabalho. O objetivo deste estudo foi avaliar funcionalidade, dor, qualidade de vida e sono de indivíduos com artralgia crônica por CHIKV correlacionada com sintomas clínicos, produtividade do trabalho e comprometimento das atividades. MÉTODOS: Trata-se de um estudo transversal descritivo com 61 pacientes crônicos de artralgia da CHIKV. A intensidade e a interferência da dor foram medidas usando a Escala Analógica Visual (EAV) e o Brief Pain Inventory Short Form (BPI), respectivamente. A qualidade de vida e o sono foram avaliados usando o Short Form 36 Health Survey (SF-36) e o Pittsburgh Sleep Quality Index (PSQI), respectivamente. O questionário Work Productivity and Activity Impairment (WPAI) foi usado para avaliar os efeitos dos sintomas gerais da saúde no trabalho. RESULTADOS: Foi observado um nível de funcionalidade baixo em 39,4% e moderado em 55,7% da amostra. Nível de dor moderada (5,57 ± 2,25), má qualidade do sono (47,54%) e distúrbios do sono (42,63%) também foram observados. O teste de Pearson apresentou correlação significativa entre absenteísmo e presenteísmo com as pontuações de Health Assessment Questionnaire (HAQ) (p = 0,03; r = 0,39 e p = 0,01; r = 0,43 respectivamente), interferência do BPI (p = 0,02; r = 0,41 e p = 0,001; r = 0,58 respectivamente) e score físico do SF-36 (p = 0,007; r = -0,49 e p = 0,01; r = 0,58, respectivamente). O comprometimento da atividade mostrou uma correlação significativa com o HAQ (p = 0,01; r = 0,44), interferência do BPI (p = 0,006; r = 0,5), pontuação física do SF-36 (p = 0,01; r = -0,6) e pontuação total do SF-36 (p = 0,01; r = -0,44). A perda geral de produtividade no trabalho correlacionou-se apenas com a interferência do BPI (p = 0,04; r = 0,37). CONCLUSÃO: Esses resultados sugerem que a artralgia crônica da CHIKV apresenta dor moderada bilateral em grandes articulações com impacto nas atividades de vida diária, produtividade no trabalho e atividade funcional. DESTAQUES A Chikungunya crônica reduz a funcionalidade e causa dor moderada e má qualidade do sono. Os sintomas clínicos afetam atividades de vida diária, a produtividade no trabalho e comprometimento de atividades. Funcionalidade, dor e sono estão correlacionados com o desempenho profissional.
RESUMO
Fibromyalgia is a rheumatologic condition characterized by multiple and chronic body pain, and other typical symptoms such as intense fatigue, anxiety and depression. It is a very complex disease where treatment is often made by non-medicated alternatives in order to alleviate symptoms and improve the patient's quality of life. Herein, we propose a method to detect patients with fibromyalgia (n = 252, 126 controls and 126 patients with fibromyalgia) through the analysis of their blood plasma using attenuated total reflection Fourier-transform infrared (ATR-FTIR) spectroscopy in conjunction with chemometric techniques, hence, providing a low-cost, fast and accurate diagnostic approach. Different chemometric algorithms were tested to classify the spectral data; genetic algorithm with linear discriminant analysis (GA-LDA) achieved the best diagnostic results with a sensitivity of 89.5% in an external test set. The GA-LDA model identified 24 spectral wavenumbers responsible for class separation; amongst these, the Amide II (1,545 cm-1) and proteins (1,425 cm-1) were identified to be discriminant features. These results reinforce the potential of ATR-FTIR spectroscopy with multivariate analysis as a new tool to screen and detect patients with fibromyalgia in a fast, low-cost, non-destructive and minimally invasive fashion.
